Hetrombopag: A promising thrombopoietin receptor agonist for the treatment of primary and secondary immune thrombocytopenia

Abstract Immune thrombocytopenia (ITP) is a rare autoimmune disorder characterized by a platelet count below 100 × 109/L. This review aims to comprehensively summarize the current evidence on the use of thrombopoietin receptor agonists (TPO‐RAs), with a focus on Hetrombopag, for the treatment of bot...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Jiaqi Hu, Zhida Fu, Xia Xu, Zhengyi Jin, Xinyu Qian, Weiyu Tao, Taiyan Ma, Dongbao Zhao, Jie Gao
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2025-06-01
Schriftenreihe:	Rheumatology & Autoimmunity
Schlagworte:	hetrombopag immune disease therapy immune thrombocytopenia thrombopoietin receptor agonist treatment
Online-Zugang:	https://doi.org/10.1002/rai2.70000
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!